Cited by 123Diabetes Management and ResearchDiabetes Management and EducationIntravenous Infusion Technology and Safety

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey

Open access

Pickup, John C., Yemane, Nardos, Brackenridge, Anna, Pender, Siobhan·2014·Diabetes Technology & Therapeutics

DOI 10.1089/dia.2013.0192PMC PMC3934434

Open this paper in CoChat — free account

Abstract

Background Little is known about the frequencies and types of nonmetabolic complications occurring in type 1 diabetes patients being treated by modern insulin pump therapy (continuous subcutaneous insulin infusion [CSII]), when recorded by standardized questionnaire rather than clinical experience. Subjects and methods A self-report questionnaire was completed by successive subjects with type 1 diabetes attending an insulin pump clinic, and those with a duration of CSII of ≥6 months were selected for analysis (n=92). Questions included pump manufacturer, insulin, infusion set type and duration of use, frequency of infusion set and site problems, pump malfunctions, and patient-related problems such as weight change since starting CSII. Results Median (range) duration of CSII was 3.3 (0.5-32.0) years, and mean ± SD duration of infusion set use was 3.2 ± 0.7 (range 2-6) days. The commonest infusion set problems were kinking (64.1% of subjects) and blockage (54.3%). Blockage was associated with >3 days of use of infusion sets plus lispro insulin in the pump (relative risk [95% confidence interval], 1.71 [1.03-2.85]; P=0.07). The commonest infusion site problem was lipohypertrophy (26.1%), which occurred more often in those with long duration of CSII (4.8 [2.38-9.45] vs. 3.0 [1.50-4.25] years; P=0.01). Pump malfunction had occurred in 48% of subjects (43% in the first year of CSII), with "no delivery," keypad, and battery problems commonly occurring. Although some patients reporte…

Integrity signals

Registry

Crossref · 10.1089/dia.2013.0192

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Self-citation
Use of Insulin Pump Therapy in the Pediatric Age-Group
Phillip, M., Battelino, T., Rodriguez, H., Danne, T., KAUFMAN, F. R., & participants, F. T. C. F. (2007) · Diabetes Care · doi:10.2337/dc07-9922 · Cited by 311
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
Self-citation
Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections
Retnakaran, R. R., Hochman, J., DeVries, J. H., Hanaire, H. P., Heine, R. J., Melki, V., & Zinman, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2590 · Cited by 214
Diabetic Lipohypertrophy Delays Insulin Absorption
Young, R. J., Hannan, W. J., Frier, B. M., Steel, J. M., & Duncan, L. J. P. (1984) · Diabetes Care · doi:10.2337/diacare.7.5.479 · Cited by 145
Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and Adolescents
Conwell, L. S., Pope, E., Artiles, A. M., Mohanta, A., Daneman, A., & Daneman, D. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.10.006 · Cited by 111
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy
Bruttomesso, D., Costa, S., & Baritussio, A. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.931 · Cited by 98
Pilot Study for Assessment of Optimal Frequency for Changing Catheters in Insulin Pump Therapy—Trouble Starts on Day 3
Schmid, V., Hohberg, C., Borchert, M., Forst, T., & Pfützner, A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400429 · Cited by 97
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life
Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E., Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M., Moretti, M., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00750.x · Cited by 83

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 1

National Institute for Health and Clinical Excellence: Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology Appraisal Guidance 151 (Review of Technology Appraisal Guidance 57). London: NICE 2008.

Sorted by citations

New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286
American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Advances in technology for management of type 1 diabetes
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31142-0 · Cited by 242
Self-citation
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Aldred, J. L., Freire-Álvarez, E., Амелин, А. В., Antonini, A., Bergmans, B. A., Bergquist, F., Bouchard, M., Budur, K., Carroll, C., Chaudhuri, К. R., et al. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00533-1 · Cited by 140
Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell Therapy
Latres, E., Finan, D. A., Greenstein, J. L., Kowalski, A. J., & Kieffer, T. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.007 · Cited by 124
Preserving Skin Integrity with Chronic Device Use in Diabetes
Messer, L. H., Berget, C., Beatson, C. R., Polsky, S., & Forlenza, G. P. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0080 · Cited by 113
Clinical review: insulin pump-associated adverse events in adults and children
Ross, P., Milburn, J., Reith, D. M., Wiltshire, E. J., & Wheeler, B. J. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0784-2 · Cited by 99
Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact
Ji, L., Sun, Z., Li, Q., Qin, G., Wei, Z., Liu, J., Chandran, A., & Hirsch, L. J. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0334 · Cited by 91
Insulin Pump Therapy
Nimri, R., Nir, J., & Phillip, M. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001097 · Cited by 76
Insulin Infusion Set Use: European Perspectives and Recommendations
Deiss, D., Adolfsson, P., Alkemade-van Zomeren, M., Bolli, G. B., Charpentier, G., Cobelli, C., Danne, T., Girelli, A., Mueller, H., Verderese, C. A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.07281.sf · Cited by 62
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes
Deeb, A., Abdelrahman, L., Tomy, M., Suliman, S., Aklé, M., Smith, M., & Strauss, K. (2019) · Diabetes Therapy · doi:10.1007/s13300-018-0561-7 · Cited by 61
Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons
Thabit, H., & Hovorka, R. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1115013 · Cited by 60
Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study
Pfützner, A., Sachsenheimer, D., Grenningloh, M., Heschel, M., Walther-Johannesen, L., Gharabli, R., & Klonoff, D. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815604438 · Cited by 53
The Injection Technique Factor: What You Don’t Know or Teach Can Make a Difference
Hirsch, L. J., & Strauss, K. W. (2018) · Clinical Diabetes · doi:10.2337/cd18-0076 · Cited by 50
Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type
Ross, P., Gray, A. R., Milburn, J., Kumarasamy, I. M., Wu, F., Farrand, S., Armishaw, J., Wiltshire, E. J., Rayns, J. A., Tomlinson, P. A., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0897-2 · Cited by 48
Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release
Weber, C., Kammerer, D., Streit, B., & Licht, A. H. (2014) · Toxicology Reports · doi:10.1016/j.toxrep.2014.11.019 · Cited by 49
Closed-loop insulin delivery: update on the state of the field and emerging technologies
Ware, J., & Hovorka, R. (2022) · Expert Review of Medical Devices · doi:10.1080/17434440.2022.2142556 · Cited by 47
A Review of Safety and Hazards Associated With the Artificial Pancreas
Ramkissoon, C. M., Aufderheide, B., Bequette, B. W., & Vehı́, J. (2017) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2017.2749038 · Cited by 41
Insulin Delivery Using Dynamic Covalent Boronic Acid/Ester‐Controlled Release
Banach, Ł., Williams, G. T., & Fossey, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100118 · Cited by 41
Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters
Hauzenberger, J. R., Münzker, J., Kotzbeck, P., Asslaber, M., Bubalo, V., Joseph, J. I., & Pieber, T. R. (2018) · Scientific Reports · doi:10.1038/s41598-017-18790-0 · Cited by 41
Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
Hauzenberger, J. R., Hipszer, B. R., Loeum, C., McCue, P. A., DeStefano, M., Torjman, M. C., Kaner, M. T., Dinesen, A. R., Chervoneva, I., Pieber, T. R., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0175 · Cited by 39
“The success of insulin pump therapy may further be dependent on the robustness of insertion methods to avoid issues such as catheter kinking and therefore failed delivery of insulin into the tissue.(18,19) We hypothesize that the flow of insulin from a CSII catheter into adjacent vascular tissue is affected by the cha…”
Background
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
Bally, L., Thabit, H., & Hovorka, R. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.022 · Cited by 41
Patch Pumps: Are They All the Same?
Heinemann, L., Waldenmaier, D., Kulzer, B., Ziegler, R., Ginsberg, B. H., & Freckmann, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818795150 · Cited by 38
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional
Kalra, S., Mithal, A., Sahay, R. K., John, M., Unnikrishnan, A., Saboo, B., Ghosh, S. K., Sanyal, D., Hirsch, L. J., Gupta, V., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0244-9 · Cited by 36
Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review
Jedlowski, P. M., Te, C., Segal, R. J., & Fazel, M. T. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0400-7 · Cited by 36
Barriers to Type 1 Diabetes Adherence in Adolescents
Azar, S., Jaoude, N. M. A., Kędzia, A. W., & Niechciał, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195669 · Cited by 47
Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
Verhoeff, K. K., Henschke, S., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2021) · Cells · doi:10.3390/cells10020278 · Cited by 34
Insulin Pump Failures: Has There Been an Improvement? Update of a Prospective Observational Study
Guénégo, A., Bouzillé, G., Breitel, S., Esvant, A., Poirier, J.-Y., Bonnet, F., & Guilhem, I. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0265 · Cited by 33
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies
Gibney, M., Xue, Z., Swinney, M., Bialonczyk, D., & Hirsch, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0342 · Cited by 32
Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study
Alderisio, A., Bozzetto, L., Franco, L., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.06.008 · Cited by 30
Improving Patient Experience With Insulin Infusion Sets
Evert, A. B., Bode, B. W., Buckingham, B. A., Nardacci, E., Verderese, C. A., Wolff-McDonagh, P., Walsh, J. S. A., & Hirsch, I. B. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716642526 · Cited by 29
Psychosocial Aspects of Diabetes Technology
Polonsky, W. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.003 · Cited by 29
Insulin Infusion Sets: A Critical Reappraisal
Heinemann, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0013 · Cited by 30
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Brazg, R., Garg, S. K., Bhargava, A., Thrasher, J. R., Latif, K., Bode, B. W., Bailey, T. S., Horowitz, B. S., Cavale, A., Kudva, Y. C., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0540 · Cited by 28
An injectable and biodegradable zwitterionic gel for extending the longevity and performance of insulin infusion catheters
Zhang, E., Shi, Y., Han, X., Zhu, H. J., Song, B., Yang, C., & Cao, Z. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01108-z · Cited by 28
Nitric oxide-releasing semi-crystalline thermoplastic polymers: preparation, characterization and application to devise anti-inflammatory and bactericidal implants
Wang, X., Jolliffe, A., Carr, B. D., Zhang, Q., Bilger, M., Cui, Y., Wu, J., Wang, X., Mahoney, M., Rojas-Peña, Á., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm00849c · Cited by 27
Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
Regittnig, W., Tschaikner, M., Tuca, A., Simic, A., Feiel, J., Schaller‐Ammann, R., Licht, A. H., Jungklaus, M., & Pieber, T. R. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14594 · Cited by 27
How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models
Amaral, M., Martins, A. S., Catarino, J., Faísca, P., Kumar, P., Pinto, J. F., Pinto, R. M. A., Correia, I., Ascensão, L., Afonso, R. A., et al. (2020) · Biomolecules · doi:10.3390/biom10050675 · Cited by 26
Patch Pumps: What are the advantages for people with diabetes?
Kulzer, B., Freckmann, G., Heinemann, L., Schnell, O., Hinzmann, R., & Ziegler, R. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109858 · Cited by 30
Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey
Taleb, N., Messier, V., Ott-Braschi, S., Ardilouze, J.-L., & Rabasa-Lhoret, R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.035 · Cited by 25
Tissue Response to Subcutaneous Infusion Catheter
Zhang, E., & Cao, Z. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819837972 · Cited by 24
A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
Waldenmaier, D., Zschornack, E., Buhr, A., Pleus, S., Haug, C., & Freckmann, G. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0445 · Cited by 23
Capacity of Infusion Lines for Insulin Adsorption: Effect of Flow Rate on Total Adsorption
Knopp, J. L., Bishop, K., Lerios, T., & Chase, J. G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819876924 · Cited by 22
Oral Coadministration of Zn-Insulin with d -Form Small Intestine-Permeable Cyclic Peptide Enhances Its Blood Glucose-Lowering Effect in Mice
Ito, S., Torii, Y., Chikamatsu, S., Harada, T., Yamaguchi, S., Ogata, S., Sonoda, K., Wakayama, T., Masuda, T., & Ohtsuki, S. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01010 · Cited by 21
Multi-step ahead predictive model for blood glucose concentrations of type-1 diabetic patients
Zaidi, S. M. A., Chandola, V., Ibrahim, M., Romanski, B., Mastrandrea, L. D., & Singh, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-03341-5 · Cited by 19
Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditions
Jick, S. S., Oleske, D. M., Persson, R., Zamudio, J., & Facheris, M. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1953971 · Cited by 19
In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue
EISLER, G. J., Kastner, J. R., Torjman, M. C., Khalf, A., Diaz, D., Dinesen, A. R., Loeum, C., Thakur, M. L., Strasma, P. J., & Joseph, J. I. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000881 · Cited by 18
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review
Bonato, L., Taleb, N., Gingras, V., Messier, V., Gobeil, F., Ménard, J., Ardilouze, J., & RABASA-LHORET, R. P. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0110 · Cited by 19
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1‐year cohort study
Rabbone, I., Minuto, N., Bonfanti, R., Marigliano, M., Cerutti, F., Cherubini, V., d’Annunzio, G., Frongia, A. P., Iafusco, D., Ignaccolo, M. G., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13294 · Cited by 17
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
Kim, J. Y., Jin, S.-M., Kang, E. S., Kwak, S. H., Yang, Y., Yoo, J. H., Bae, J. H., Moon, J. S., Jung, C. H., Bae, J. C., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06155-y · Cited by 17
Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia
Rincón, A. R., Hincapié-García, J. A., Monsalve, C., Aristizábal, N., Castillo, E., Hincapie, G., Zapata, E., Cuesta, D., Delgado, M., Abad, V., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0166 · Cited by 17
Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life
Freckmann, G., Arndt, S., Fießelmann, A., Klausmann, G., Pralle, K., Künsting, T., & Petersen, B. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816667510 · Cited by 15
New advances in insulin products
Rajpoot, K., Tekade, M., Sharma, M. C., Molugulu, N., & Tekade, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814455-8.00014-1 · Cited by 15
Perception and Possible Causes of Skin Problems to Insulin Pump and Glucose Sensor: Results from Pediatric Focus Groups
Berg, A., Simonsen, A., & Svensson, J. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0089 · Cited by 16
Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1‐year prospective observational study with suggestions to minimize clinical impact
Rabbone, I., Minuto, N., Toni, S., Lombardo, F., Iafusco, D., Marigliano, M., Schiaffini, R., Maltoni, G., Frongia, A. P., Scardapane, M., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13419 · Cited by 15
The role of Toll-like receptor signaling in the macrophage response to implanted materials
McKiel, L. A., Woodhouse, K. A., & Fitzpatrick, L. E. (2019) · MRS Communications · doi:10.1557/mrc.2019.154 · Cited by 15
Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes
Kastner, J. R., Venkatesh, N., Brown, K., Muchmore, D. B., Ekinci, E. I., Fourlanos, S., Joseph, J. I., Shafeeq, M., Shi, L., Strange, P., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14685 · Cited by 14
Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases
Ziegler, A., Williams, T., Yarid, N., Schultz, D. L., & Bundock, E. A. (2019) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13841 · Cited by 14
Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
Senn, J.-D., Fischli, S., Slahor, L., Schelbert, S., & Henzen, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030394 · Cited by 14
Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin Delivery
Yu, T. S., Song, S., Yea, J., & Jang, K. (2024) · Advanced Sensor Research · doi:10.1002/adsr.202400048 · Cited by 14
Insulin Pump Malfunction During Hospitalization: Two Case Reports
Faulds, E. R., Wyne, K. L., Buschur, E., McDaniel, J. C., & Dungan, K. M. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0434 · Cited by 12
Insulin injection knowledge, attitude and behaviour of nurses: A cross‐sectional study in Guangdong Province
Liao, Y., Liu, X., Huang, J., Chen, Q., Li, N., & Zhou, P. (2023) · Nursing Open · doi:10.1002/nop2.1633 · Cited by 11
Insulin pumps in children - a systematic review
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., & Elbeltagi, R. M. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i6.463 · Cited by 15
Insulin Pumping Patches: Emerging Insulin Delivery Systems
Thompson, B., & Cook, C. B. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818814541 · Cited by 11
Concept and Implementation of a Novel Patch Pump for Insulin Delivery
Ulbrich, S. E., Waldenmaier, D., Haug, C., Freckmann, G., Rendschmidt, T., & Künsting, T. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819871626 · Cited by 12
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time
Kastner, J. R., EISLER, G. J., Torjman, M. C., Khalf, A., Diaz, D., Dinesen, A. R., Loeum, C., Strasma, P. J., & Joseph, J. I. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221093362 · Cited by 11
Inflammation at Site of Insulin Infusion Diminishes Glycemic Control
Kesserwan, S., Lewis, B. E., Mao, L., Sharafieh, R., Atwood, T., Kreutzer, D. L., & Klueh, U. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.12.025 · Cited by 10
A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes
Chatziravdeli, V., Lambrou, G. Ι., Samartzi, A., Kotsalas, N., Vlachou, E. D., Komninos, J., & Tsartsalis, A. N. (2023) · Medicina · doi:10.3390/medicina59010141 · Cited by 9
Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes
Estock, J. L., Codario, R. A., Keddem, S., Zupa, M. F., Rodriguez, K. L., & DiNardo, M. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0498 · Cited by 9
‘Striving for freedom or remaining with what is well-known’: a focus-group study of self-management among people with type 1 diabetes who have suboptimal glycaemic control despite continuous subcutaneous insulin infusion
Persson, M., Leksell, J. K., Ernersson, Å., Rosenqvist, U., & Hörnsten, Å. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057836 · Cited by 8
Insulin Pumps
Pickup, J. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.2503 · Cited by 8
Self-citation
Safety of the batteries and power units used in insulin pumps: A pilot cross‐sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan
Murata, T., Nirengi, S., Sakane, N., Kuroda, A., Hirota, Y., Matsuhisa, M., Namba, M., & Kobayashi, T. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12765 · Cited by 8
Evaluating the impact of an insulin pump discontinuation action plan on patient or caregiver confidence and anxiety
Milburn, J., de Lange, M., Wiltshire, E. J., Ross, P., Rayns, J. A., Tomlinson, P. A., Wu, F., Kumarasamy, I. M., Armishaw, J., & Wheeler, B. J. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00393-3 · Cited by 7
Insulin infusion sets associated with adverse events: strategies for improved diabetes education
Neves, A. L. D., Martins, L. E. G., Gabbay, M. A. L., Pascali, P. M., de Oliveira, T., Martinazzo, A., Dib, S. A., Casarini, D. E., Arêdes, S. V., Tenório, F. S., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1275394 · Cited by 6
Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children
Neves, A. L. D., Martins, L. E. G., Gabbay, M. A. L., Cavicchioli, G., Tenório, F. S., & Cunha, T. S. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221106196 · Cited by 6
NUEVAS TECNOLOGÿAS EN DIABETES
Apablaza, P., Néstor Soto, I., Román, R., & Ethel Codner, D. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.04.011 · Cited by 9
Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature
Hendel, K., Stumpe, T., & Özer, K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221138076 · Cited by 6
De la bomba de insulina y el monitoreo continuo de glucosa al páncreas artificial
Apablaza, P., Néstor Soto, I., & Ethel Codner, D. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000500011 · Cited by 9
First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
Waldenmaier, D., Zschornack, E., Kalt, L., Buhr, A., Pleus, S., Haug, C., & Freckmann, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818785386 · Cited by 5
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
Klimontov, V. V., Lazarev, M. M., Makhotin, A. A., Letyagin, A. Y., Anisimova, L. A., Мухтаровна, Б. Д., Koroleva, E. A., & Lykov, A. P. (2018) · Diabetes Mellitus · doi:10.14341/dm9549 · Cited by 5
Insights for personalized choice of a hybrid closed–loop system: an expert opinion
Molfetta, S. D., Boscari, F., Rossi, A., Girelli, A., Lepore, G., Bozzetto, L., Irace, C., Laviola, L., & Bruttomesso, D. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113120 · Cited by 4
Insulin Distribution in Human Adipose Tissue via a Novel Insulin Infusion Catheter
Altendorfer‐Kroath, T., Schwingenschuh, S., Schøndorff, P. K., Heschel, M., Sinner, F. M., & Birngruber, T. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0195 · Cited by 4
Insulin-induced skin lipohypertrophies: A neglected cause of hypoglycemia in dialysed individuals with diabetes
Gentile, S., Satta, E., Strollo, F., Guarino, G., Romano, C., Corte, T. D., & Alfarone, C. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.018 · Cited by 4
Observational Study of the Impact of Infusion Set Replacement in Insulin Pump Users on Glycemic Management
Yoshimura, K., Urai, S., Hozumi, K., Nakatsuji, M., Saito, S., Nishikage, S., Yamamoto, A., Takayoshi, T., Ogawa, W., & Hirota, Y. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251345837 · Cited by 4
Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial
Kurnikowski, A., Werzowa, J. M., Hödlmoser, S., Krenn, S., Paschen, C., Mußnig, S., Tura, A., Harreiter, J., Krebs, M., Song, P. X. ‐., et al. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100860 · Cited by 3
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Bruttomesso, D., Petrie, J. R., Evans, M., Fleming, G. A., Hanaire, H. P., Holl, R. W., Sherr, J. L., Bergenstal, R. M., Heinemann, L., & Peters, A. L. (2026) · Diabetologia · doi:10.1007/s00125-025-06651-9 · Cited by 2
L’éducation des patients présentant des lipohypertrophies a-t-elle un impact sur l’équilibre glycémique ?
Strauss, K. W. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30100-1 · Cited by 2
A Three-Arm Randomized Controlled Study Comparing Patient-Reported Outcomes in People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Barnard-Kelly, K. D., Thienel, F., Mader, J. K., Oliver, N. S., Franek, E., Vesper, I., DAGENBACH, N., Vogt, G., ETTER, T. J., & Künsting, T. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241234055 · Cited by 2
Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis
Mader, J. K., Fornengo, R., Hassoun, A. A. K., Heinemann, L., Kulzer, B., Monica, M., Nguyen, T. T., Sieber, J., Renard, É., Reznik, Y., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251319806 · Cited by 2
Optimal Insulin Delivery
Frid, A. H., Hirsch, L. J., & Strauss, K. W. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76232 · Cited by 2
Practical Implementation of Diabetes Technology: It Is Time
Messer, L. H. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2512 · Cited by 2
Relationships between quality of life and comprehensive geriatric assessment among seniors — a cross-sectional study in Krakow, Poland
Pachołek, A., Oniszczuk, E. R. S. , Mierzwa, J., Wróbel, A., Piotrowicz, K., Gąsowski, J., & Tomasik, T. (2023) · Folia Medica Cracoviensia · doi:10.24425/fmc.2023.145426 · Cited by 2
Knowledge, Attitude, and Practice of Insulin Pump Among Non-Endocrinology Nurses in South China
Mo, C., Huang, X.-F., Lu, X., Zhou, Y., Su, Y., & Zhang, H.-H. (2023) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s414327 · Cited by 1
Faults And Fault Tolerance In Automated Insulin Delivery Systems With An Emphasis On Human-In-The-Loop
Ibrahim, M., Beneyto, A., Contreras, I., & Vehı́, J. (2023) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2023.10.441 · Cited by 1
A Qualitative Evidence Synthesis of Continuous Subcutaneous Insulin Infusion: Acceptability, Implementation, Equity
Toledo‐Chávarri, A., Delgado, J., Padilla-Ruiz, M., & Rodríguez‐Martin, B. (2024) · Nursing and Health Sciences · doi:10.1111/nhs.13177 · Cited by 1
The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
Risi, R., Pauletto, D., Buffi, V. Z., Berna, V., Carafa, A., Barbaro, F., Vita, F. D., D’Onofrio, L., Amendolara, R., Pantano, A. L., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70629 · Cited by 1
Analysis of “Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life”
Renard, É. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816675177 · Cited by 1
Avaliação dos Efeitos da Transição de Múltiplas Injeções Diárias de Insulina para Infusão Subcutânea Contínua de Insulina no Tratamento Intensivo da Diabetes Mellitus Tipo 1
Oliveira, S. C., Neves, C., Esteves, C., Neves, J. S., Oliveira, A., Pereira, M., Arteiro, C., Costa, A. D., Redondo, M., Baltazar, R., et al. (2019) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao190004 · Cited by 1
Insulin Pumps
Pickup, J. C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.1503.s · Cited by 1
Self-citation
Severe Insulin Pump-Related Adverse Events: Potential Root Causes and Impact of the COVID-19 Pandemic
Orbell, S. L., Codario, R. A., Zupa, M. F., & Estock, J. L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241254521 · Cited by 1

Authors: Pickup, J. C., Yemane, N., Brackenridge, A., & Pender, S.
Affiliations: Guy's Hospital (GB)
Guy's and St Thomas' NHS Foundation Trust (GB)
Corresponding author: Pickup, John C.
ORCID: Pickup, John C.
Brackenridge, Anna
Venue: Diabetes Technology & Therapeutics
Publisher: SAGE Publications
Published: 2014-03
Volume: 16
Issue: 3
Pages: 145-149
ISSN: 1520-9156 (ISSN-L)
1557-8593
DOI: 10.1089/dia.2013.0192
PMC: PMC3934434
OpenAlex: W2094458427
Cited by: 123
References: 22
Citations by year: 2026: 4 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 3 · 2019: 20 · 2018: 18 · 2017: 10 · 2016: 15 · 2015: 6 · 2014: 1
FWCI: 5.78
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Diabetes Technology & Therapeutics (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: Eli Lilly and Company
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
Keywords: insulin pump therapy, type 1 diabetes, lipohypertrophy, pump failure, insulin lispro, weight change, patient survey
MeSH terms: Adipose Tissue, Adult, Diabetes Mellitus, Type 1, Female, Humans, Hypertrophy, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Surveys and Questionnaires, Risk Factors, Weight Gain, Prevalence, Odds Ratio, Treatment Outcome, Health Care Surveys, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks